{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:14:18Z","timestamp":1784121258904,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,3,12]],"date-time":"2007-03-12T00:00:00Z","timestamp":1173657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1471-2334-7-15","type":"journal-article","created":{"date-parts":[[2007,3,13]],"date-time":"2007-03-13T06:30:18Z","timestamp":1173767418000},"source":"Crossref","is-referenced-by-count":19,"title":["The cause of urinary symptoms among Human T Lymphotropic Virus Type I (HLTV-I) infected patients: a cross sectional study"],"prefix":"10.1186","volume":"7","author":[{"given":"Paulo N","family":"Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Rehem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana F","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neviton","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre L","family":"Muniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heonir","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar M","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,12]]},"reference":[{"key":"458_CR1","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1086\/514143","volume":"176","author":"EL Murphy","year":"1997","unstructured":"Murphy EL, Glynn SA, Fridey J, Sacher RA, Smith JW, Wright DJ, Newman B, Gibble JW, Ameti DI, Nass CC, Schreiber GB, Nemo GJ: Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group. J Infect Dis. 1997, 176: 1468-1475.","journal-title":"J Infect Dis"},{"key":"458_CR2","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/archinte.159.13.1485","volume":"159","author":"EL Murphy","year":"1999","unstructured":"Murphy EL, Glynn SA, Fridey J, Smith JW, Sacher RA, Nass CC, Ownby HE, Wright DJ, Nemo GJ: Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors. Retrovirus Epidemiology Donor Study. Arch Intern Med. 1999, 159: 1485-1491. 10.1001\/archinte.159.13.1485.","journal-title":"Arch Intern Med"},{"key":"458_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3201\/eid1001.020714","volume":"10","author":"EL Murphy","year":"2004","unstructured":"Murphy EL, Wang B, Sacher RA, Fridey J, Smith JW, Nass CC, Newman B, Ownby HE, Garratty G, Hutching ST, Schreiber GB: Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection. Emerg Infect Dis. 2004, 10: 109-116.","journal-title":"Emerg Infect Dis"},{"key":"458_CR4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/00126334-200312150-00013","volume":"34","author":"I Dourado","year":"2003","unstructured":"Dourado I, Alcantara LC, Barreto ML, da Gloria TM, Galvao-Castro B: HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr. 2003, 34: 527-531. 10.1097\/00126334-200312150-00013.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"458_CR5","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983, 33: 1444-1452.","journal-title":"Neurology"},{"key":"458_CR6","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1089\/aid.2006.22.931","volume":"22","author":"CM De Castro-Costa","year":"2006","unstructured":"De Castro-Costa CM, Araujo AQ, Barreto MM, Takayanagui OM, Sohler MP, da Silva EL, de Paula SM, Ishak R, Ribas JG, Rovirosa LC, Carton H, Gotuzzo E, Hall WW, Montano S, Murphy EL, Oger J, Remondegui C, Taylor GP: Proposal for Diagnostic Criteria of Tropical Spastic Paraparesis\/HTLV-I-Associated Myelopathy (TSP\/HAM). AIDS Res Hum Retroviruses. 2006, 22: 931-935. 10.1089\/aid.2006.22.931.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"458_CR7","volume-title":"Supplemental table M100-S4 to: Performance standards for antimicrobial disk susceptibility tests, 4th ed. Document M2-A4, 1990","author":"National Committee for Clinical Laboratory Standards","year":"1992","unstructured":"National Committee for Clinical Laboratory Standards: Supplemental table M100-S4 to: Performance standards for antimicrobial disk susceptibility tests, 4th ed. Document M2-A4, 1990. 1992, Villanova, Pa"},{"key":"458_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/0002-9343(83)90072-4","volume":"75","author":"R Platt","year":"1983","unstructured":"Platt R: Quantitative definition of bacteriuria. Am J Med. 1983, 75: 44-52. 10.1016\/0002-9343(83)90072-4.","journal-title":"Am J Med"},{"key":"458_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1590\/S0104-42302003000100043","volume":"49","author":"IP Heilberg","year":"2003","unstructured":"Heilberg IP, Schor N: [Diagnosis and clinical management of urinary tract infection]. Rev Assoc Med Bras. 2003, 49: 109-116. 10.1590\/S0104-42302003000100043.","journal-title":"Rev Assoc Med Bras"},{"key":"458_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/sc.1989.32","volume":"27","author":"S Komine","year":"1989","unstructured":"Komine S, Yoshida K, Yamashita H, Masaki Z: Voiding dysfunction in patients with human T-lymphotropic virus type-1-associated myelopathy (HAM). Paraplegia. 1989, 27: 217-221.","journal-title":"Paraplegia"},{"key":"458_CR11","first-page":"475","volume":"81","author":"T Namima","year":"1990","unstructured":"Namima T, Sohma F, Imabayashi K, Nishimura Y, Orikasa S: [Two cases of neurogenic bladder due to HTLV-1 associated myelopathy (HAM)]. Nippon Hinyokika Gakkai Zasshi. 1990, 81: 475-478.","journal-title":"Nippon Hinyokika Gakkai Zasshi"},{"key":"458_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1464-410X.1991.tb15351.x","volume":"68","author":"M Saito","year":"1991","unstructured":"Saito M, Kondo A, Kato K, Gotoh M: Bladder dysfunction due to human T-lymphotrophic virus type I associated myelopathy. Br J Urol. 1991, 68: 365-368.","journal-title":"Br J Urol"},{"key":"458_CR13","first-page":"1005","volume":"37","author":"M Saito","year":"1991","unstructured":"Saito M, Kato K, Kondo A, Miyake K: [Neurogenic bladder in HAM (HTLV-I associated myelopathy)]. Hinyokika Kiyo. 1991, 37: 1005-1008.","journal-title":"Hinyokika Kiyo"},{"issue":"Suppl 1","key":"458_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000282255","volume":"47","author":"H Yamashita","year":"1991","unstructured":"Yamashita H, Kumazawa J: Voiding dysfunction: patients with human T-lymphotropic-virus-type-1-associated myelopathy. Urol Int. 1991, 47 (Suppl 1): 69-71.","journal-title":"Urol Int"},{"key":"458_CR15","first-page":"2058","volume":"83","author":"H Sakiyama","year":"1992","unstructured":"Sakiyama H, Nishi K, Kikukawa H, Ueda S: [Urinary disturbance due to HTLV-1 associated myelopathy]. Nippon Hinyokika Gakkai Zasshi. 1992, 83: 2058-2061.","journal-title":"Nippon Hinyokika Gakkai Zasshi"},{"key":"458_CR16","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0022-5347(17)35652-5","volume":"150","author":"GW Walton","year":"1993","unstructured":"Walton GW, Kaplan SA: Urinary dysfunction in tropical spastic paraparesis: preliminary urodynamic survey. J Urol. 1993, 150: 930-932.","journal-title":"J Urol"},{"key":"458_CR17","first-page":"1106","volume":"85","author":"A Imamura","year":"1994","unstructured":"Imamura A: [Studies on neurogenic bladder due to human T-lymphotropic virus type-I associated myelopathy (HAM)]. Nippon Hinyokika Gakkai Zasshi. 1994, 85: 1106-1115.","journal-title":"Nippon Hinyokika Gakkai Zasshi"},{"key":"458_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00002517-199407030-00010","volume":"7","author":"T Hattori","year":"1994","unstructured":"Hattori T, Sakakibara R, Yamanishi T, Yasuda K, Hirayama K: Micturitional disturbance in human T-lymphotropic virus type-1-associated myelopathy. J Spinal Disord. 1994, 7: 255-258.","journal-title":"J Spinal Disord"},{"key":"458_CR19","first-page":"451","volume":"72","author":"SA Mehnert-Kay","year":"2005","unstructured":"Mehnert-Kay SA: Diagnosis and management of uncomplicated urinary tract infections. Am Fam Physician. 2005, 72: 451-456.","journal-title":"Am Fam Physician"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-7-15\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T04:45:24Z","timestamp":1548218724000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-7-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,12]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["458"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-7-15","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,12]]},"article-number":"15"}}